A randomized double-blind placebo-controlled trial of thioctic acid in migraine prophylaxis.
Impaired mitochondrial phosphorylation potential may play a role in migraine pathogenesis. Metabolic enhancers, such as riboflavin or coenzyme Q, are effective in migraine prophylaxis and quasi-devoid of adverse effects. Thioctic acid (-lipoic acid) is another substance known to enhance energy metabolism in mitochondria and to be beneficial in diabetic neuropathy. After an open pilot study suggesting its therapeutic antimigraine potentials, we embarked therefore in a randomized controlled trial of thioctic acid (Thioctacid) in migraine prophylaxis steered by the Belgian Headache Society. Five... Mehr ...
Verfasser: | |
---|---|
Dokumenttyp: | Artikel |
Erscheinungsdatum: | 2007 |
Schlagwörter: | Adult / Belgium / Double-Blind Method / Energy Metabolism / Female / Humans / Male / Middle Aged / Migraine Disorders / Mitochondria / Severity of Illness Index / Thioctic Acid / Treatment Outcome / Vitamin B Complex / Migraine prophylaxis |
Sprache: | Englisch |
Permalink: | https://search.fid-benelux.de/Record/base-27367497 |
Datenquelle: | BASE; Originalkatalog |
Powered By: | BASE |
Link(s) : | http://hdl.handle.net/2078.1/235444 |